Collateral for a security interest recorded Mar 16, 2026 (Symbiotic Capital Agency LLC).
Term ends Mar 9, 2029 · Medium confidence
20-year base term ends Jan 28, 2029
Why Medium: A parent in the chain could not be resolved.
Held by Vero Biotech Inc.
Filed Jul 15, 2019 as application 16/512,021 · Granted Apr 26, 2022
Base term plus 40 days of patent term adjustment (USPTO delay)
Today
2009
2029
Clock starts
Jan 28, 2009
Jan 28, 2009
Term ends
Mar 9, 2029
Mar 9, 2029
Granted
Apr 26, 2022
Apr 26, 2022
base term
patent term adjustment
fee events
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
40
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
1 of 1
Maintenance fees paid
One maintenance fee can end this term early, the one due 3.5 years from grant; the next one's grace period runs past the term end. This counts it if the record shows it paid.
11
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term runs 40 days past its 20-year base term on prosecution delay. 1 of 1 maintenance fees is paid so far. Confidence: Medium. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Jan 28, 2009, when application 12/361,274, the earliest non-provisional in its chain, was filed (this one was filed Jul 15, 2019); a parent in its chain could not be resolved (the next row) | Jan 28, 2029 | High confidence |
| Continuity chain | A parent in the chain could not be resolved | dated from this application's own claim | Medium confidence |
| Patent term adjustment | +40 days, USPTO patent term adjustment record | Mar 9, 2029 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 1 of 1 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Mar 9, 2029 | Medium confidence |
This family
| US 7,914,743 | In force Jun 2029 | Jun 2029 |
| Application PCT/US2009/032254 | PCT application no patent term | no patent term |
| US 8,187,544 | In force Jan 2029 | Jan 2029 |
| US 8,609,026 | In force Jan 2029 | Jan 2029 |
| US 8,741,222 | In force Jan 2029 | Jan 2029 |
| US 9,701,538 | In force Jan 2029 | Jan 2029 |
| US 10,081,544 | In force Jan 2029 | Jan 2029 |
| Application 16/140,497 | Abandoned not computed | not computed |
8 of 11 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Dec 29, 2020 Reel 54866, frame 589 | Vero Biotech LLC | Runway Growth Credit Fund Inc. | Security Interest |
| Mar 16, 2022 Reel 59281, frame 476 | Fine, David; Vasquez, Gregory; Rounbehler, David P. | Geno LLC | Assignment of Assignor's Interest |
| Mar 16, 2022 Reel 59369, frame 504 | Geno LLC | Vero Biotech LLC | Change of Name |
| Mar 16, 2022 Reel 59369, frame 507 | Vero Biotech LLC | Vero Biotech Inc. | Change of Name |
| Jan 3, 2024 Reel 66186, frame 611 | Runway Growth Finance Corp. (F/K/A Runway Growth Credit Fund Inc.) | Vero Biotech Inc. (F/K/A Vero Biotech LLC) | Termination and Release of Intellectual Property Security Agreement |
| Jan 3, 2024 Reel 66187, frame 865 | Vero Biotech Inc. | Horizon Technology Finance Corporation | Security Interest |
| Mar 16, 2026 Reel 75117, frame 935 | Vero Biotech Inc. | Symbiotic Capital Agency LLC, as Collateral Agent | Security Interest |
| Mar 18, 2026 Reel 75308, frame 198 | Horizon Technology Finance Corporation | Vero Biotech Inc. | Release of Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Mar 2029
Term ends Mar 9, 2029. No further fees fall due before then
Note
The 40 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
24
later US patents cite this one
That is top 5% of utility patents granted in 2022 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.